{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:24:51Z","timestamp":1775841891318,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s11906-020-01096-4","type":"journal-article","created":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T02:02:15Z","timestamp":1599444135000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Psychiatric Medications and Hypertension"],"prefix":"10.1007","volume":"22","author":[{"given":"M. K.","family":"Morreale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. A.","family":"Wake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,7]]},"reference":[{"key":"1096_CR1","doi-asserted-by":"crossref","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey Jr DE, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith Jr SC, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams Sr KA, Williamson JD, Wright Jr JT Guideline for the prevention, detection, evaluation and management of high blood pressure in adults. A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.J Am Coll Cardiol 2018;71 (19): e127\u2013e248.","DOI":"10.1161\/HYP.0000000000000065"},{"key":"1096_CR2","unstructured":"Mental health by the numbers. www.nami.org\/mhstats Accessed 5\/20\/2020."},{"key":"1096_CR3","unstructured":"Mozaffarian D, Benjamin EJ, Go AS et al. Heart disease and stroke statistics-2016 update. A report from the American Heart Association. Circulation. 2016 Jan 26; 133(4): e38\u2013360."},{"key":"1096_CR4","unstructured":"Miller B. The heavy economic burden of schizophrenia. Psychiatr Times 2016 Oct 10."},{"issue":"12","key":"1096_CR5","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1097\/01.jom.0000100000.70011.bb","volume":"45","author":"RC Kessler","year":"2003","unstructured":"Kessler RC, Ormel J, Demler O, Stang PE. Comorbid mental disorders account for the role of impairment of commonly occuring physical disorders. J Occup Environ Med. 2003 Dec;45(12):1257\u20136.","journal-title":"J Occup Environ Med"},{"issue":"9","key":"1096_CR6","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1097\/HJH.0000000000001006","volume":"34","author":"I Maatouk","year":"2016","unstructured":"Maatouk I, Herzog W, Bohlen F, et al. Association of hypertension with depression and generalized anxiety symptoms in a large population-based sample of older adults. J Hypertens. 2016 Sep;34(9):1711\u201320.","journal-title":"J Hypertens"},{"key":"1096_CR7","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jad.2017.09.002","volume":"225","author":"L Ayerbe","year":"2018","unstructured":"Ayerbe L, Forgnone I, Addo J, Siguero A, Gelati S, Ayis S. Hypertension risk and clincial care in patients with bipolar disorder or schizophrenia; a systematic review and meta-analysis. J Affect Disord. 2018 Jan;225:665\u201370.","journal-title":"J Affect Disord"},{"issue":"5","key":"1096_CR8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1017\/S2045796017000166","volume":"27","author":"J Westman","year":"2018","unstructured":"\u2022 Westman J, Eriksson SV, Gissler M, et al. Increased cardiovascular mortality in people with schizophrenia: a 24-year national register study. Epidemiol Psychiatr Sci. 2018;27(5):519\u201327. This large study of a Swedish national registry highlights the disparity in cardiovascular outcomes for patients with severe and persistent mental illness when compared to the general population.","journal-title":"Epidemiol Psychiatr Sci"},{"issue":"8","key":"1096_CR9","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1001\/archgenpsychiatry.2009.81","volume":"66","author":"M Olson","year":"2019","unstructured":"Olson M, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry. 2019 Aug;66(8):848\u201356.","journal-title":"Arch Gen Psychiatry"},{"key":"1096_CR10","doi-asserted-by":"publisher","first-page":"i1350","DOI":"10.1136\/bmj.i1350","volume":"352","author":"C Coupland","year":"2016","unstructured":"Coupland C, Hill T, Morriss R. Antidepressant use and risk of cardiovascular outcomes in people aged 20-64: cohort study using primary care database. BMJ. 2016;352:i1350.","journal-title":"BMJ"},{"key":"1096_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.psym.2014.09.002","volume":"56","author":"RR Tampi","year":"2015","unstructured":"Tampi RR, Balderas M, Carter K, et al. Citalopram, QTc prolongation, and torsade de pointes. Psychosomatics. 2015;56:36\u201343.","journal-title":"Psychosomatics"},{"key":"1096_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4103\/1735-1995.189647","volume":"21","author":"MH Nezafati","year":"2016","unstructured":"Nezafati MH, Eshraghi A, Vojdanparast M, Abtahi S, Nezafati P. Selective serotonin reuptake inhibitors and cardiovascular events: a systematic review. J Res Med Sci. 2016 Sep;21:66.","journal-title":"J Res Med Sci"},{"key":"1096_CR13","doi-asserted-by":"publisher","first-page":"502","DOI":"10.4088\/JCP.v59n1002","volume":"59","author":"M Thase","year":"1998","unstructured":"Thase M. Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients. J Clin Psychiatry. 1998;59:502\u20138.","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"1096_CR14","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.ecl.2019.08.013","volume":"48","author":"MC Foy","year":"2019","unstructured":"Foy MC, Vaishnav J, Sperati CJ. Drug-induced hypertension. Endocrinol Met Clin North Am. 2019 Dec;48(4):859\u201373.","journal-title":"Endocrinol Met Clin North Am"},{"issue":"5","key":"1096_CR15","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.pcad.2015.11.003","volume":"58","author":"RM Teply","year":"2016","unstructured":"Teply RM, Packard KA, White ND, Hilleman DE, DiNicolantonio JJ. Treatment of depression in patients with concomitant cardiac disease. Prog Cardiovasc Dis. 2016;58(5):514\u201328.","journal-title":"Prog Cardiovasc Dis"},{"issue":"2","key":"1096_CR16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0733-8627(20)30441-7","volume":"12","author":"L Pimentel","year":"1994","unstructured":"Pimentel L, Trommer L. Cyclic antidepressant overdose: a review. Emerg Med Clin North Am. 1994 May;12(2):533\u201347.","journal-title":"Emerg Med Clin North Am"},{"issue":"11","key":"1096_CR17","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s00702-018-1932-y","volume":"125","author":"PK Gillman","year":"2018","unstructured":"Gillman PK. A reassessment of the safety profile of monoamine oxidase inhibitors: elucidating tired old tyramine myths. J Neural Transm. 2018 Nov;125(11):1707\u201317.","journal-title":"J Neural Transm"},{"issue":"4","key":"1096_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/00131746-200407000-00005","volume":"10","author":"JG Fiedorowicz","year":"2004","unstructured":"Fiedorowicz JG, Swartz KL. The role of monoamine oxidase inhibitors in current psychiatric practice. J Psychiatr Pract. 2004 July;10(4):239\u201348.","journal-title":"J Psychiatr Pract"},{"issue":"3","key":"1096_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s40263-020-00699-4","volume":"34","author":"T Doherty","year":"2020","unstructured":"\u2022 Doherty T, Wajs E, Melkote R. Cardiac safety of esketamine nasal spray in treatment-resistant depression: results from the clinical development program. CNS Drugs. 2020;34(3):299\u2013310. This large cohort study of patients receiving the novel antidepressant, esketamine, indicates that blood pressure elevations resulting from treatment rarely requires management with antihypertensive medications and does not lead to serious cardiovascular safety sequelae.","journal-title":"CNS Drugs"},{"issue":"12","key":"1096_CR20","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/j.1751-7176.2009.00181.x","volume":"11","author":"J Handler","year":"2009","unstructured":"Handler J. Lithium and antihypertensive medication: a potentially dangerous interaction. J Clin Hypertens. 2009 Dec;11(12):738\u201342.","journal-title":"J Clin Hypertens"},{"issue":"5","key":"1096_CR21","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/j.1532-5415.2004.52221.x","volume":"52","author":"DN Juurlink","year":"2004","unstructured":"Juurlink DN, Mamdan M, Kopp A, et al. Drug-induced lithium toxicity in the elderly: a population-based study. J Am Geriatr Soc. 2004 May;52(5):794\u20138.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"1096_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4088\/JCP.19m12785","volume":"81","author":"Y Zhang","year":"2020","unstructured":"\u2022 Zhang Y, Wang Q, Reynolds GP, et al. Metabolic effects of 7 antipsychotics on patients with schizophrenia: a short-term, randomized, open-label, multicenter pharmacologic trial. J Clin Psychiatry. 2020;81(3):15\u201323. In this pharmacologic trial of atypical and typical antipsychotics, metabolic disturbances occurred within the first month of treatment, highlighting the importance of early monitoring of symptoms.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"1096_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.9758\/cpn.2013.11.2.80","volume":"11","author":"Y Ko","year":"2013","unstructured":"Ko Y, Soh M, Kang S, Lee J. The prevalence of metabolic syndrome in schizophrenic patients using antipsychotics. Clin Psychopharmacol Neurosci. 2013;11(2):80\u20138.","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"1","key":"1096_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0306-4530(02)00114-2","volume":"28","author":"H Nasrallah","year":"2003","unstructured":"Nasrallah H. A review of the effect of atypical antipsychotics on weight. Psychoneuroendocrinology. 2003;28(1):83\u201396.","journal-title":"Psychoneuroendocrinology."},{"issue":"5","key":"1096_CR25","doi-asserted-by":"publisher","first-page":"e424","DOI":"10.4088\/JCP.12m08186","volume":"74","author":"C Chen","year":"2013","unstructured":"Chen C, Huang M, Kao C, et al. Effects of adjunctive metformin on metabolic traits in nondiabetic clozapine-treated patients with schizophrenia and the effect of metformin discontinuation on body weight: a 24-week, randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2013;74(5):e424\u201330.","journal-title":"J Clin Psychiatry."},{"issue":"8","key":"1096_CR26","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2165\/11591710-000000000-00000","volume":"25","author":"JJ Gugger","year":"2011","unstructured":"Gugger JJ. Antipsychotic pharmacotherapy and orthostatic hypertension: identification and management. CNS Drugs. 2011;25(8):659\u201371.","journal-title":"CNS Drugs"},{"issue":"5","key":"1096_CR27","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/pds.1931","volume":"19","author":"T Gerhard","year":"2010","unstructured":"Gerhard T, Winterstein AG, Olfson M, Huang C, Saidi A, Crystal S. Preexisting cardiovascular conditions and pharmacological treatment of adult ADHD. Pharmacoepidemiol Drug Saf. 2010 May;19(5):457\u201364.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1096_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40263-012-0019-9","volume":"27","author":"J Martinez-Raga","year":"2013","unstructured":"Martinez-Raga J, Knecht C, Szerman N, Martinez MI. Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder. CNS Drugs. 2013;27:15\u201330.","journal-title":"CNS Drugs."},{"key":"1096_CR29","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1176\/appi.ajp.2011.11010125","volume":"169","author":"H Schelleman","year":"2012","unstructured":"Schelleman H, Bilker WB, Kimmel SE, Daniel GW, Newcomb C, Guevara JP, et al. Methylphenidate and risk of serious cardiovascular events in adults. Am J Psychiatry. 2012;169:178\u201385.","journal-title":"Am J Psychiatry"},{"issue":"20","key":"1096_CR30","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1056\/NEJMoa1110212","volume":"365","author":"WO Cooper","year":"2011","unstructured":"Cooper WO, Habel LA, Sox CM, et al. ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med. 2011;365(20):1896\u2013904.","journal-title":"N Engl J Med"},{"key":"1096_CR31","first-page":"222","volume":"51","author":"JP Feighner","year":"1990","unstructured":"Feighner JP, Boyer WF, Tyler DL, Neborski RJ. Adverse consequences of fluoxetine-MAOI combination therapy. J Clin Psychiatry. 1990;51:222\u20135.","journal-title":"J Clin Psychiatry"},{"key":"1096_CR32","doi-asserted-by":"crossref","first-page":"204512531881881","DOI":"10.1177\/2045125318818814","volume":"9","author":"M Ott","year":"2019","unstructured":"Ott M, Mannchen JK, Jamshidi F, Werneke U. Management of severe arterial hypertension associated with serotonin syndrome: a case report analysis based on systematic review techniques. Ther Adv Psychopharmacol. 2019;9:2045125318818814.","journal-title":"Ther Adv Psychopharmacol"},{"issue":"3","key":"1096_CR33","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.psc.2018.04.001","volume":"41","author":"AP Hermida","year":"2018","unstructured":"Hermida AP, Glass OM, Shafi H, McDonald WM. Electroconvulsive therapy in depression: current practice and future direction. Psychiatr Clin North Am. 2018;41(3):341\u201353.","journal-title":"Psychiatr Clin North Am"},{"issue":"1","key":"1096_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2217\/npy.14.3","volume":"4","author":"N Kerner","year":"2014","unstructured":"Kerner N, Prudic J. Current electroconvulsive therapy practice and research in the geriatric population. Neuropsychiatry. 2014 Feb;4(1):33\u201354.","journal-title":"Neuropsychiatry"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-020-01096-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11906-020-01096-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-020-01096-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T23:32:17Z","timestamp":1630971137000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11906-020-01096-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,7]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["1096"],"URL":"https:\/\/doi.org\/10.1007\/s11906-020-01096-4","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,7]]},"assertion":[{"value":"7 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"86"}}